EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Analytical Performance of the AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit

Valentina Hjelt, Agustina Dronseck iD, Aldana Magalí Schey, María Belén Martí, Luciano Civerchia iD, Ana Laura Cavatorta, Eduardo Codino, Virginia Nader, Natalia Andrea Garro, Federico Manuel Aranda, Lilia Mammana, Sergio Giamperetti und 10 weitere

Viruses · 20.08.2026 · 18 (8) · 914

DOI: 10.3390/v18080914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 20.08.2026. Verfasst von Valentina Hjelt und 21 weiteren Autor:innen. Beteiligte Einrichtung: AP Biotech, Lomas de Zamora B1832FYA, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Dengue Virus, Dengue, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AP Biotech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue is a mosquito-transmitted viral disease caused by the positive-sense RNA dengue virus (DENV), which comprises four antigenically distinct serotypes (1–4). Although DENV circulates predominantly in tropical and subtropical regions, its global incidence continues to increase. As most patients present viremia at the onset of clinical manifestations, real-time RT-PCR has become a widely adopted method for early dengue detection. The AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit enables qualitative detection of DENV RNA (serotypes 1–4) by real-time RT-PCR in serum or plasma samples. The assay was recently cleared by ANMAT (National Administration of Drugs, Food and Medical Technology) as an in vitro diagnostic (IVD) assay. The Limit of Detection (LoD) was calculated for all 4 serotypes. Clinical validation was conducted among 296 serum and 221 plasma samples previously characterized as DENV-positive and -negative specimens. Among the positive samples, 56 had serotype characterization, including 25 DENV-1 and 31 DENV-2 samples. The resulting clinical sensitivity and specificity were 97.8%, 100.0% and 100.0%, 99.1% respectively. Additional validation studies demonstrated high reproducibility across three independent laboratories, absence of cross-reactivity with other febrile pathogens, and no interference from endogenous and exogenous substances at clinical levels. Collectively, these findings support the AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit (AP Biotech, Lomas de Zamora, Argentina) as a sensitive, specific, and highly reproducible device for early dengue diagnosis and surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VirusDengueReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionReagent Kits, DiagnosticHumansSensitivity and SpecificityRNA, ViralSerogroupLimit of Detection

Stichwörter der Autor:innen

clinical validationdenguein vitro diagnostics (IVD)limit of detectionmolecular diagnosisreal-time RT-PCRspecificity

Substanzen

RNA, ViralReagent Kits, Diagnostic

Autor:innen und Institutionen

  • AP Biotech, Lomas de Zamora B1832FYA, Buenos Aires, Argentina.
  • Laboratorio Mixto de Investigación Traslacional en Salud, Centro de Tecnología en Salud Pública (CTSP), Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario S2002LRK, Santa Fe, Arge…
  • Laboratorio Central, Sanatorio Allende, Córdoba X5000BFB, Córdoba, Argentina.
  • Unidad de Virología, División Análisis Clínicos, Hospital de Infecciosas F. J. Muñiz, Ciudad Autónoma de Buenos Aires C1282AEN, Argentina.
  • Sector de Biología Molecular, División Laboratorio, Hospital General de Agudos Dr. Carlos G. Durand, Ciudad Autónoma de Buenos Aires C1405DCS, Argentina.
  • Laboratorio de Biología Molecular, Sanatorio Juncal, Temperley B1834GUK, Buenos Aires, Argentina.

ORCID-Profile: Agustina Dronseck, Luciano Civerchia, Anisa Marchissio, María Belén Bouzas, Lucila Brocardo

Förderung

  • AP Biotech

Zitieren

APA

Hjelt, V., Dronseck, A., Schey, A. M., Martí, M. B., Civerchia, L., Cavatorta, A. L., Codino, E., Nader, V., Garro, N. A., Aranda, F. M., Mammana, L., Giamperetti, S., Theaux, C., Marchissio, A., Burani, V. E., Luczak, E. N., Bellucci, M. M., García, G., Cayrol, F., …, & Brocardo, L. (2026). Clinical and Analytical Performance of the AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit. Viruses, 18(8), 914. https://doi.org/10.3390/v18080914

Vancouver

Hjelt V, Dronseck A, Schey AM, Martí MB, Civerchia L, Cavatorta AL, et al. Clinical and Analytical Performance of the AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit. Viruses. 2026;18(8):914. doi:10.3390/v18080914

BibTeX
@article{Hjelt2026,
  author = {Hjelt, Valentina and Dronseck, Agustina and Schey, Aldana Magalí and Martí, María Belén and Civerchia, Luciano and Cavatorta, Ana Laura and Codino, Eduardo and Nader, Virginia and Garro, Natalia Andrea and Aranda, Federico Manuel and Mammana, Lilia and Giamperetti, Sergio and Theaux, Clara and Marchissio, Anisa and Burani, Valeria Estefanía and Luczak, Erica Natalia and Bellucci, María Martina and García, Gabriela and Cayrol, Florencia and Bouzas, María Belén and Grutadauria, Sergio and Brocardo, Lucila},
  title = {Clinical and Analytical Performance of the AP Biotech Discovery® Dengue Virus RT-PCR Detection Kit},
  journal = {Viruses},
  year = {2026},
  volume = {18},
  number = {8},
  pages = {914},
  doi = {10.3390/v18080914}
}
Kostenlos starten →